Dr. Rahma Warsame presenting a novel PRO system in MM/AL patients; outstanding patient-centered research spotlighted at #ASH18 Mayo Myeloma #healthoutcomesresearch @rmwarsame

Our proposed new algorithm for richter patients from CLL

This ECOG-ACRIN Cancer Research Group & complementary Alliance for Clinical Trials in Oncology trial presented earlier at #ASH18 — Together, these National Cancer Institute-funded trials collectively establish ibrutinib-based therapy as the first line treatment for CLL patients of any age.

@LeoSakemura gave an outstanding talk at ASH #CARTcells Mayo Clinic Mayo Clinic Comprehensive Cancer Center

Thank you Tait Shanafelt for an excellent presentation of the E1912 trial for CLL patients...this trial reshapes the future of patient care, the EA mission #ASH18 #CLL #nctn

2/ Unknown to me, a patient with #LEMS was in the audience. She raised her hand and spoke up. She had received the drug almost for free from Jacobus Pharma for many years. But now because of Small Pharma & Catalyst this program was done. She had to buy Firdapse: at $3800/month co pay! 👇

neil kay joined Twitter too!

The role of 18F-FDG-PET in detecting Richter's transformation of CLL in patients treated with a B-cell receptor inhibitor haematologica.org/content/early/… Yucai Wang, MD, PhD Paul Hampel Wei Ding Saad kenderian

Mayo Clinic started drive-through #COVID19 testing in Rochester today, on the day that first case was confirmed in @olmstedcounty. This is the way to get quick testing, minimize exposure. #FlattenTheCurve Post Bulletin

My view on my walk into the hospital this morning. Thanks Charlie and Will for setting an example of universal masking 😷 #Masks4All Mayo Clinic

72 yo asymptomatic male with previously untreated Rai IV CLL to begin single-agent BTKi therapy. Prior to starting BTKi, which of the following tests will you do? Nitin Jain @anthonymatomd Matthew Davids, MD, MMSc Mazyar Shadman, MD MPH Saad kenderian Wei Ding neil kay

Review Article: Chronic Lymphocytic Leukemia

Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib | Blood Advances | American Society of Hematology ashpublications.org/bloodadvances/… Paul Hampel Nitin Jain

Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia theoncologist.onlinelibrary.wiley.com/doi/full/10.16… Interesting findings by our fellow Paul Hampel! Sameer Parikh Wei Ding Mayo Clinic Comprehensive Cancer Center Mayo Clinic

Fantastic presentations at the Mayo Clinic Annual Hematology Review ⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦Mrinal Patnaik⁩ ⁦Greg⁩ ⁦Witzig Laboratory⁩

MIRACLE, an investigator-initiated study of MRD-guided, time-limited frontline therapy with pirtobrutinib and venetoclax for CLL/SLL, sponsored by @LoxoLillyOnc, is now open Mayo Clinic Comprehensive Cancer Center. clinicaltrials.gov/ct2/show/NCT05…

Sameer Parikh Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽

Congratulations ⁦Paul Hampel⁩ on receiving the best abstract award at the 2024 YIM GCLLSG meeting in Koln! A fantastic conference! #GCLLSG ⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦⁦⁦Michael Hallek⁩ ⁦Deborah Stephens⁩

100 years of Hematology Mayo Clinic Rochester, MN Hematology Division Faculty Mayo Clinic Comprehensive Cancer Center

Today marks the 50th anniversary of a landmark paper in the field of CLL! The Rai Staging System, first published Blood Journals Portfolio on August 1, 1975 continues to influence clinical practice and research to this day. pubmed.ncbi.nlm.nih.gov/1139039/ iwCLL Michael Hallek Mayo Clinic Comprehensive Cancer Center